Key Details
Symbol (NSE): AGARWALEYE
Corporate Action: Amalgamation
Record Date: Not Specified
Nature of Scheme: Amalgamation of Dr. Agarwal's Eye Hospital Limited (AEHL) with and into Dr. Agarwal's Health Care Limited (AHCL)
Entities Involved:
- Transferor Company: Dr. Agarwal's Eye Hospital Limited (AEHL)
- Transferee Company: Dr. Agarwal's Health Care Limited (AHCL)
Demerged Company: Not Applicable (Amalgamation scheme)
Resulting Company: Dr. Agarwal's Health Care Limited (AHCL)
Share Entitlement Ratio: Not Specified
Implied Capital Structure Impact: Not Specified
Post-Allotment Listing Plan: AEHL will amalgamate into existing listed entity AHCL
Regulatory and Approval Status:
- NCLT Chennai Bench has sanctioned the Scheme of Amalgamation
- Order pronounced on September 30, 2026
- Certified copy of the Order awaited
- Scheme sanctioned under Sections 230 to 232 of the Companies Act, 2013
Effective Date: The Scheme shall be effective from the Appointed Date [April 1, 2026] and operative from the first day of the calendar month immediately following the calendar month in which all conditionalities mentioned in Clause 24 of the Scheme are completed.
Financial Rationale: Not Specified
Impact on Shareholders: Not Specified
Additional Details
Reference Number: AHCL/2026-27/C045
Disclosure Date: October 5, 2026
Regulatory Reference: Regulation 30 read with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
NCLT Order Status: Order uploaded on NCLT website on October 5, 2026; certified copy awaited
Next Steps: Company will inform stock exchanges regarding effectiveness of Scheme, fixation of Record Date, allotment of shares as per Share Exchange Ratio, and other subsequent developments